Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Oct 10, 2023
Open Peer Review Period: Oct 17, 2023 - Dec 17, 2023
Date Accepted: Mar 21, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial

Chappell KD, Meakins D, Marsh-Joyal M, Bihari A, Goodman KJ, Le Melledo JM, Lim A, Peerani F, Kroeker KI

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial

JMIR Form Res 2024;8:e53550

DOI: 10.2196/53550

PMID: 38709548

PMCID: 11106704

Integrating Virtual Mindfulness-Based Stress Reduction into Inflammatory Bowel Disease Care: A Mixed Methods Feasibility Trial

  • Kaitlyn Delaney Chappell; 
  • Diana Meakins; 
  • Melanie Marsh-Joyal; 
  • Allison Bihari; 
  • Karen Jean Goodman; 
  • Jean-Michel Le Melledo; 
  • Allen Lim; 
  • Farhad Peerani; 
  • Karen Ivy Kroeker

ABSTRACT

Background:

Individuals with Inflammatory bowel disease (IBD) experience psychological distress including symptoms of anxiety and depression; however, these symptoms often remain untreated.

Objective:

This study aimed to evaluate the feasibility, acceptability, and effectiveness of virtual Mindfulness-Based Stress Reduction (v-MBSR) for adults with IBD.

Methods:

IBD patients with self-reported anxiety or depression were recruited from clinics in Alberta, Canada to participate in an 8-week v-MSBR intervention. Eligible patients participated in v-MBSR delivered by psychiatrists using a videoconferencing platform. Primary feasibility outcomes included trial uptake, adherence, attendance, and attrition rates. Secondary effectiveness outcomes included measures of anxiety, depression, quality of life, and mindfulness. Effectiveness data was collected at three timepoints: baseline, at intervention completion, and 6 months after completion. To further assess feasibility and acceptability, participants were invited to participate in a semi-structured interview after completing v-MBSR.

Results:

Sixteen of sixty-four (25%) referred patients agreed to participate in v-MBSR with the most common reason for decline being a lack of time. Seven of the 16 (43.8%) participants completed the program and experienced encouraging effects including decreased anxiety and depression symptoms and increased health-related quality of life with both improvements persisting at 6-month follow-up. Participants described improved coping strategies and disease management techniques as benefits of v-MBSR.

Conclusions:

IBD patients were interested in a psychiatrist-led virtual anxiety management intervention, but results demonstrate v-MBSR may be too time intensive for some IBD patients. v-MBSR was acceptable to those who completed the intervention and improvements to anxiety, depression, and quality of life were promising and sustainable.


 Citation

Please cite as:

Chappell KD, Meakins D, Marsh-Joyal M, Bihari A, Goodman KJ, Le Melledo JM, Lim A, Peerani F, Kroeker KI

Integrating Virtual Mindfulness-Based Stress Reduction Into Inflammatory Bowel Disease Care: Mixed Methods Feasibility Trial

JMIR Form Res 2024;8:e53550

DOI: 10.2196/53550

PMID: 38709548

PMCID: 11106704

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.